Antibodies to antigenic site a of influenza H7 hemagglutinin provide protection against H7N9 challenge

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Schmeisser, Falko ^a   Vasudevan, Anupama ^a   Verma, Swati ^a   Wang, Wei ^a   Alvarado, Esmeralda ^a   Weiss, Carol ^a   Atukorale, Vajini ^a   Meseda, Clement ^a   Weir, Jerry P ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY COMBINING SITE; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGENICITY; ARTICLE; CHINA; CONTROLLED STUDY; CROSS REACTION; EMBRYO; EPITOPE MAPPING; INFECTION PREVENTION; INFLUENZA A; INFLUENZA A (H7N9); INFLUENZA VIRUS A H7N9; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PASSIVE TRANSPORT; TREATMENT OUTCOME; VIRUS LIKE AGENT; VIRUS STRAIN; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS (H7N9); INFLUENZA, HUMAN; VIROLOGY;

MAMMALIA; MURINAE;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; EPITOPES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 84961288661     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117108     Document Type: Article

References (25)

1. Gao R, Cao B, Hu Y, Feng Z, Wang D, et al. (2013) Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. N Engl J Med 368: 1888-1897. doi: 10.1056/NEJMoa1304459 PMID: 23577628
2. Li Q, Zhou L, Zhou M, Chen Z, Li F, et al. (2014) Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med 370: 520-532. doi: 10.1056/NEJMoa1304617 PMID: 23614499
3. Belser JA, Davis CT, Balish A, Edwards LE, Zeng H, et al. (2013) Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis. J Virol 87: 5746-5754. doi: 10.1128/JVI.00154-13 PMID: 23487452
4. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, et al. (2004) Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 101: 1356-1361. PMID: 14745020
5. Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, et al. (2004) Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363: 587-593. PMID: 14987882
6. Jadhao SJ, Achenbach J, Swayne DE, Donis R, Cox N, et al. (2008) Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine. Vaccine 26: 1742-1750. doi: 10.1016/j.vaccine.2008.01.036 PMID: 18336962
7. Pappas C, Matsuoka Y, Swayne DE, Donis RO (2007) Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness. Clin Vaccine Immunol 14: 1425-1432. PMID: 17913860
8. Whiteley A, Major D, Legastelois I, Campitelli L, Donatelli I, et al. (2007) Generation of candidate human influenza vaccine strains in cell culture-rehearsing the European response to an H7N1 pandemic threat. Influenza Other Respir Viruses 1: 157-166. doi: 10.1111/j.1750-2659.2007.00022.x PMID: 19432631
9. Couch RB, Patel SM, Wade-Bowers CL, Nino D (2012) A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine. PLoS One 7: e49704. doi: 10.1371/journal.pone.0049704 PMID: 23239968
10. Cox RJ, Madhun AS, Hauge S, Sjursen H, Major D, et al. (2009) A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. Vaccine 27: 1889-1897. doi: 10.1016/j.vaccine.2009.01.116 PMID: 19368768
11. Bart SA, Hohenboken M, Della Cioppa G, Narasimhan V, Dormitzer PR, et al. (2014) A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults. Sci Transl Med 6: 234ra255.
12. Fries LF, Smith GE, Glenn GM (2013) A recombinant viruslike particle influenza A (H7N9) vaccine. N Engl J Med 369: 2564-2566. doi: 10.1056/NEJMc1313728 PMID: 24369087
13. Gaush CR, Hard WL, Smith TF (1966) Characterization of an established line of canine kidney cells (MDCK). Proc Soc Exp Biol Med 122: 931-935. PMID: 5918973
14. Schmeisser F, Friedman R, Besho J, Lugovtsev V, Soto J, et al. (2013) Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin. Influenza Other Respi Viruses 7: 480-490. doi: 10.1111/irv.12029 PMID: 23122228
15. Schmeisser F, Adamo JE, Blumberg B, Friedman R, Muller J, et al. (2012) Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase. Vaccine 30: 3413-3422. doi: 10.1016/j.vaccine.2012.03.033 PMID: 22465746
16. Palmer DF, Coleman MT, Dowdle WR, Schild GC (1975) Advanced Laboratory Techniques for Influenza Diagnosis. Washington, D.C.: U.S. Department of Health, Education and Welfare. PMID: 25077283
17. Matrosovich M, Matrosovich T, Garten W, Klenk HD (2006) New low-viscosity overlay medium for viral plaque assays. Virol J 3: 63. PMID: 16945126
18. Wang W, Butler EN, Veguilla V, Vassell R, Thomas JT, et al. (2008) Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies. J Virol Methods 153: 111-119. doi: 10.1016/j.jviromet.2008.07.015 PMID: 18722473
19. Wang W, Xie H, Ye Z, Vassell R, Weiss CD (2010) Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays. J Virol Methods 165: 305-310. doi: 10.1016/j.jviromet.2010.02.009 PMID: 20153374
20. Wiley DC, Skehel JJ (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56: 365-394. PMID: 3304138
21. Wiley DC, Wilson IA, Skehel JJ (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289: 373-378. PMID: 6162101
22. Goff PH, Krammer F, Hai R, Seibert CW, Margine I, et al. (2013) Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin. J Virol 87: 8235-8240. doi: 10.1128/JVI.01085-13 PMID: 23698299
23. Guo L, Zhang X, Ren L, Yu X, Chen L, et al. (2014) Human antibody responses to avian influenza A (H7N9) virus, 2013. Emerg Infect Dis 20: 192-200. doi: 10.3201/eid2002.131094 PMID: 24447423
24. Caton AJ, Brownlee GG, Yewdell JW, GerhardW(1982) The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31: 417-427. PMID: 6186384
25. Gerhard W, Yewdell J, Frankel ME, Webster R (1981) Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290: 713-717. PMID: 6163993